{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:42Z","timestamp":1786119342278,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/scs.0b013e3181c347a0","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:28:48Z","timestamp":1263947328000},"page":"25-32","source":"Crossref","is-referenced-by-count":15,"title":["Bisphosphonate-Related Osteonecrosis of the Jaw"],"prefix":"10.1097","volume":"21","author":[{"given":"Robert John W.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rtshiladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Lvoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sherring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210208","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.joms.2004.09.004","article-title":"Bis-phossy jaw, phossy jaw, and the 21st century: bisphosphonate-associated complications of the jaws.","volume":"62","author":"Hellstein","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"R3-5-20210208","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/joms.2003.50095","article-title":"A case of maxillary necrosis.","volume":"61","author":"Pogrel","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"R4-5-20210208","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"R5-5-20210208","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1001\/jama.295.24.2833","article-title":"Reports of adverse events from bone drugs prompt caution.","volume":"295","author":"Kuehn","year":"2006","journal-title":"JAMA"},{"key":"R6-5-20210208","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0714.2005.00351.x","article-title":"Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.","volume":"34","author":"Merigo","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"R7-5-20210208","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","article-title":"Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.","volume":"65","author":"Wang","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R8-5-20210208","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.joms.2006.02.011","article-title":"Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?","volume":"64","author":"Zavras","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"R9-5-20210208","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates.","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-5-20210208","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.","volume":"66","author":"Wessel","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"R11-5-20210208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R12-5-20210208","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMcpc0800341","article-title":"Case 9-2008-a 65-year-old woman with a nonhealing ulcer of the jaw.","volume":"358","author":"Dodson","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-5-20210208","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"R14-5-20210208","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMe078051","article-title":"Treatments for osteoporosis-looking beyond the HORIZON.","volume":"356","author":"Compston","year":"2007","journal-title":"N Engl J Med"},{"key":"R15-5-20210208","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/annonc\/mdi206","article-title":"Jaw avascular necrosis associated with long-term use of bisphosphonates.","volume":"16","author":"Sanna","year":"2005","journal-title":"Annal Oncol"},{"key":"R16-5-20210208","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone an emerging oral complication of supportive cancer therapy.","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"R17-5-20210208","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcms.2005.07.007","article-title":"Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?","volume":"33","author":"Lenz","year":"2005","journal-title":"J Craniomaxillofac Surg"},{"key":"R18-5-20210208","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone rhPTH(1-34).","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R19-5-20210208","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.scs.0000221517.80361.6f","article-title":"Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.","volume":"17","author":"Graziani","year":"2006","journal-title":"J Craniofac Surg"},{"key":"R20-5-20210208","first-page":"260","article-title":"Can 'double blockbuster' strengthen Amgen's backbone?","volume":"26","author":"Sheridan","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R21-5-20210208","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R22-5-20210208","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.","volume":"9","author":"Santini","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R23-5-20210208","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/rheumatology\/kem106","article-title":"Bisphosphonates and osteonecrosis of the jaw.","volume":"46","author":"Shenker","year":"2007","journal-title":"Rheumatology"},{"key":"R24-5-20210208","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.joms.2006.04.003","article-title":"A time for perspective on bisphosphonates.","volume":"64","author":"Assael","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"R25-5-20210208","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/01.scs.0000249350.59096.d0","article-title":"New therapeutic protocol in the treatment of avascular necrosis of the jaws.","volume":"17","author":"Agrillo","year":"2006","journal-title":"J Craniofac Surg"},{"key":"R26-5-20210208","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.joms.2007.08.017","article-title":"Bone marrow edema: mild or nascent variant of ischemic bone disease.","volume":"66","author":"Bouquot","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R27-5-20210208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0714.2007.00540.x","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.","volume":"36","author":"Hewitt","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"R28-5-20210208","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","article-title":"Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.","volume":"14","author":"Sarin","year":"2008","journal-title":"Oral Dis"},{"key":"R29-5-20210208","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S8756-3282(03)00112-1","article-title":"Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.","volume":"33","author":"Bagger","year":"2003","journal-title":"Bone"},{"key":"R30-5-20210208","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"R31-5-20210208","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy.","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"R32-5-20210208","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.joms.2006.10.043","article-title":"Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case.","volume":"65","author":"Senel","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R33-5-20210208","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.joms.2004.04.007","article-title":"Osteonecrosis: a multifactorial etiology.","volume":"62","author":"McMahon","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"R34-5-20210208","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/JCM.44.5.1719-1725.2006","article-title":"Viable bacteria present within oral squamous cell carcinoma tissue.","volume":"44","author":"Hooper","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R35-5-20210208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/mp.56.2.97","article-title":"Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells.","volume":"56","author":"Kinjo","year":"2003","journal-title":"Mol Pathol"},{"key":"R36-5-20210208","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrgentox.2008.09.017","article-title":"Oxidative stress in environmental-induced carcinogenesis.","volume":"674","author":"Mena","year":"2008","journal-title":"Mutat Res"},{"key":"R38-5-20210208","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1359\/jbmr.060712","article-title":"Osteonecrosis of the jaw: more research needed.","volume":"21","author":"Shane","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R39-5-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","article-title":"Osteonecrosis of the jaw related to the use of bisphosphonates.","volume":"19","author":"Van den Wyngaert","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R40-5-20210208","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"R41-5-20210208","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.joms.2007.11.025","article-title":"Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws.","volume":"66","author":"Vescovi","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"R42-5-20210208","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","article-title":"Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.","volume":"65","author":"Freiberger","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R43-5-20210208","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2002-221061","article-title":"New bone formation with teriparatide human parathyroid hormone-(1-34) is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.","volume":"144","author":"Ma","year":"2003","journal-title":"Endocrinology"},{"key":"R44-5-20210208","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"},{"key":"R45-5-20210208","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejca.2006.12.006","article-title":"International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.","volume":"43","author":"Body","year":"2007","journal-title":"European Journal of Cancer"},{"key":"R46-5-20210208","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R47-5-20210208","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4065\/81.8.1047","article-title":"Mayo Clinic consensus statement for the use of bisphosphonates in multiple myeloma.","volume":"81","author":"Lacy","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R48-5-20210208","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.joms.2005.12.068","article-title":"Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction.","volume":"65","author":"Curi","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R49-5-20210208","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.joms.2006.07.012","article-title":"Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?","volume":"65","author":"Engroff","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R50-5-20210208","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/scs.0b013e3180f611ef","article-title":"Surgical therapy for osteonecrotic lesions of the jaws in patients in therapy with bisphosphonates.","volume":"18","author":"Longobardi","year":"2007","journal-title":"J Craniofac Surg"},{"key":"R51-5-20210208","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4065\/81.8.1100","article-title":"Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.","volume":"81","author":"Kademani","year":"2006","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Craniofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SCS.0b013e3181c347a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:14Z","timestamp":1786040354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001665-201001000-00005"}},"subtitle":["Tip of the Iceberg"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/scs.0b013e3181c347a0","relation":{},"ISSN":["1049-2275"],"issn-type":[{"value":"1049-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}